Clinical trials for Bladder cancer

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Bladder cancer. For all clinical trials, go to clinical trials search

This list shows clinical trials for Bladder cancer

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Bladder cancer
Title Recruitment status Location
A Phase III randomised trial of PeriOperative chemotherapy versus sUrveillance in upper Tract urothelial cancer Recruiting United Kingdom
Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer Recruiting United Kingdom
Open-Label, Randomised, Multi-Drug, Biomarker-Directed, Phase 1b Study in Pts w/ Muscle Invasive Bladder Cancer Recruiting United Kingdom
Evaluating the biological effects of pre-operative intravenous administration of JX-594 (thymidine kinase-deactivated Vaccinia virus plus GM-CSF) prior to planned surgical resection of locally advanced/poor prognosis or metastatic cancers. Recruiting United Kingdom
Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder Cancer Recruiting United Kingdom
Photodynamic versus white light-guided treatment of non-muscle invasive bladder cancer Recruiting United Kingdom
Standard open radical cystectomy (ORC) versus robotically assisted radical cystectomy (RARC) Recruiting United Kingdom
Safety and Tolerability of GemRIS 225 mg in Subjects With Non-Muscle-Invasive Bladder Cancer Recruiting United Kingdom
NEOadjuvant chemotherapy study of Nintedanib with Gemcitabine and Cisplatin in locally advanced muscle invasive BLADder cancEr Recruiting United Kingdom
Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom Recruiting United Kingdom

Page last reviewed: 11/05/2015

Next review due: 01/05/2018